Science Talk

We’ve learned a lot about cancer in the last decade, with survival rates better now than ever before. Our Policy Adviser, Roya Ziaie, takes a look at what might be in store over the next ten years in an ever-changing field.

Dr Max Douglas recently joined the ICR as leader of the Telomere Biology Team. By rebuilding telomeres in the lab, he aims to unpick how they work to understand their link to cancer. Diana Cano Bordajandi met him to find out more.

Scientists at The Institute of Cancer Research have already been involved in the discovery and development of many targeted treatments that are helping cancer patients live longer and with a better quality of life. Now we’re taking our research a step further with the world’s first drug discovery programme to tackle the challenge of drug resistance. Christine O’Connell, who is living with advanced breast cancer, explains why it’s so important.